VRDN — Viridian Therapeutics, Inc.

VRDNViridian Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · viridiantherapeutics.com

17.22USD-0.12%Mkt Cap: 1.88B USDP/E: —Last update: 2026-05-26

Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED), including Veligrotrug, a diff…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap1.88B USD

Enterprise Value1.25B USD

Revenue (TTM)70.92M USD

Gross Profit-268.72M USD

Net Income (TTM)-342.60M USD

Revenue/Share0.7880 USD

Last Price17.22 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees252

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-7.05

PEG—

EV/EBITDA-3.24

EV/Revenue17.58

P/S27.55

P/B3.05

EPS (TTM)-3.35

EPS (Forward)-2.51

52W Range

13.1819% of range34.29

52W High34.29 USD

52W Low13.18 USD

Profitability

Gross Margin0.00%

Oper. Margin-82389.36%

EBITDA Margin0.00%

Profit Margin-483.57%

ROE-47.44%

ROA-38.09%

Growth

Revenue Growth95.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF-276.39M USD

CapEx (TTM)495.00K USD

FCF Margin-257.41%

FCF Yield-9.70%

Net Debt-708.83M USD

Net Debt/EBITDA1.84

Balance Sheet

Debt/Equity0.07

Current Ratio15.15

Quick Ratio14.71

Book Value/Sh5.795 USD

Cash/Share7.394 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateNov 13, 2020

Splits

Last Split1:15

Split DateNov 13, 2020

Analyst Consensus

Rating1.3 (Strong Buy)

Target (Mean)33.94 USD

Target Range20.00 USD – 50.00 USD

# Analysts16

Ownership

Shares Out.110.43M

Float103.02M

Insiders0.14%

Institutions109.76%

Short Interest

Short Ratio3.4d

Short % Float11.62%

Short % Out.11.17%

Shares Short11.51M

Short (prev mo.)10.84M

Technical

SMA 5018.68 (-7.8%)

SMA 20024.31 (-29.2%)

Beta0.82

S&P 52W Chg28.31%

Avg Vol (30d)2.93M

Avg Vol (10d)2.52M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—